Search

Your search keyword '"Anna L. Brown"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Anna L. Brown" Remove constraint Author: "Anna L. Brown"
118 results on '"Anna L. Brown"'

Search Results

1. TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

2. Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy

Catalog

Books, media, physical & digital resources

3. Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

4. Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss

5. The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy

6. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

7. Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

8. Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity

9. Facile Synthesis of Ligand-Free Iridium Nanoparticles and Their In Vitro Biocompatibility

11. Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration

12. Novel modes of MPL activation in triple-negative myeloproliferative neoplasms

13. Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations

14. Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease

15. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

16. TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

17. Somatic mutational landscape of hereditary hematopoietic malignancies associated with germline variants in RUNX1, GATA2 and DDX41

18. Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia

19. Clonal hematopoiesis in individuals with ANKRD26 or ETV6 germline mutations

20. Cover, Volume 42, Issue 11

21. To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition

22. B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations

23. Childhood acute myeloid leukemia shows a high level of germline predisposition

24. GATA2 deficiency syndrome: a decade of discovery

25. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

26. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

27. A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability

28. Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss

29. Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative

30. Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis

31. Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia

32. Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes

33. Myeloid neoplasms with germline DDX41 mutation

34. DDX41-related myeloid neoplasia

35. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML

36. ClinGen myeloid malignancy variant curation expert panel recommendations for germline RUNX1 variants

37. A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia

38. Genomic subtyping and therapeutic targeting of acute erythroleukemia

39. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

41. What’s germane in the germline? Finding clinically relevant germline variants in myeloid neoplasms from tumor only screening

42. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

43. Bismuth-Based Nano- and Microparticles in X-Ray Contrast, Radiation Therapy, and Radiation Shielding Applications

44. Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration

45. Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

46. Aerobic method for the synthesis of nearly size-monodisperse bismuth nanoparticles from a redox non-innocent precursor

47. Facile Synthesis of Ligand-Free Iridium Nanoparticles and Their In Vitro Biocompatibility

49. A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone

50. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Comparing in vitro 2D and 3D-tumor model of triple-negative breast cancer